Skip to main content
SpringerLink
Log in
Book cover

Morbus Bechterew pp 211–245Cite as

Gastrointestinale Komplikationen

  • Chapter

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aalykke C, Lauritsen JM, Hallas J, et al (1999) Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study. Gastroenterology 116:1305–1309

    PubMed  Google Scholar 

  • Actis GC, Bresso F, Astegiano M, et al (2001) Safety and efficacy of azathioprine in the maintenance of cyclosporin-induced remission of ulcerative colitis. Aliment Pharmacol Ther 15:1307–1311

    Article  PubMed  Google Scholar 

  • Bargen JA (1929) Complications and sequelae of chronic ulcerative colitis. Ann Intern Med 3:335

    Google Scholar 

  • Best WR, Becktel JM, Singleton JW (1979) Rederived values of the eight coefficiencies of the Crohn’s Disease Activity Index (CDAI) Gastroenterology 77:843–846

    Google Scholar 

  • Bernstein CN, Blanchard JF, Rawsthorne P, Yu N (2001) The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96:1116–1122

    PubMed  Google Scholar 

  • Bjarnason I, Fehilly B, Smethurst P, Menzies IS, Levi AJ (1991) Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man. Gut 32:275–277

    PubMed  Google Scholar 

  • Bjarnason I, Hayllar J, Smethurst P, Price A, Gumpel MJ (1992) Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut 33:1204–1208

    PubMed  Google Scholar 

  • Bocanegra TS, Weaver AL, Tindall EA, et al (1998) Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group. J Rheumatol 25:1602–1611

    PubMed  Google Scholar 

  • Bombardier C, Laine L, Reicin A, et al (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 343:1520–1528

    Article  PubMed  Google Scholar 

  • Bourne JT, Kumar P, Huskisson EC, et al (1985) Arthritis and coeliac disease. Ann Rheum Dis 44:592–598

    PubMed  Google Scholar 

  • Brandt J, Haibel H, Sieper J, et al (2001) Infliximab treatment of severe ankylosing spondylitis: one-year followup. Arthritis Rheum 44:2936–2937

    PubMed  Google Scholar 

  • Braun J, de Keyser F, Brandt J, et al (2001) New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy. Curr Opin Rheumatol 13:245–249

    PubMed  Google Scholar 

  • Camma C, Giunta M, Rosselli M, Cottone M (1997) Mesalamine in the maintenance treatment of Crohn’s disease: a meta-analysis adjusted for confounding variables. Gastroenterology 113:1465–1473

    PubMed  Google Scholar 

  • Chan FKL (2002) Helicobacter pylori, NSAIDs and gastrointestinal haemorrhage. Eur J Gastroenterol Hepatol 4:1–3

    Google Scholar 

  • Chan FKL, Sung JJY, Chung SC, et al (1997) Randomised trial of eradication of helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 350:975–979

    Article  PubMed  Google Scholar 

  • Chan FKL, Chung SC, Suen BY, et al (2001) Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 344:967–973

    PubMed  Google Scholar 

  • Chan FKL, Hung LCT, Suen BY, et al (2002) Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 347:2104–2110

    Article  PubMed  Google Scholar 

  • Cohen RD, Stein R, Hanauer SB (1999) Intravenous cyclosporin in ulcerative colitis: a five-year experience Am J Gastroenterol 94:1587–1592

    Article  PubMed  Google Scholar 

  • Crane AM, Bradbury L, van Heel DA, et al (2002) Role of NOD2 variants in spondylarthritis. Arthritis Rheum 46:1629–1633

    Article  PubMed  Google Scholar 

  • Cryer B (2002) Nonsteroidal anti-inflammatory drugs and gastrointestinal disease. In: Feldman M, Friedmann, Sleisenger MH (Hrsg) Sleisenger & Fordtran’s Gastrointestinal and Liver Disease. Saunders, Philadelphia, pp 408–430

    Google Scholar 

  • d’Albasio G, Pacini F, Camarri E, et al (1997) Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study. Am J Gastroenterol 92:1143–1147

    PubMed  Google Scholar 

  • d’Albasio G, Paoluzi P, Campieri M, et al (1998) Maintenance treatment of ulcerative proctitis with mesalazine suppositories: a double-blind placebo-controlled trial. The Italian IBD Study Group. Am J Gastroenterol 93:799–803

    Article  PubMed  Google Scholar 

  • Davies NM, Saleh JY, Skjodt NM (2000) Detection and prevention of NSAID-induced enteropathy. J Pharm Pharmaceut Sci 3:137–155

    Google Scholar 

  • de Vlam K, Mielants H, Cuvelier C, et al (2000) Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol 27:2860–2865

    PubMed  Google Scholar 

  • de Vos M, Mielants H, Cuvelier C, Elewaut A, Veijs E (1996) Long-term evolution of gut inflammation in patients with spondylarthropathy. Gastroenterology 110:1696–1703

    PubMed  Google Scholar 

  • Dominguez-Lopez ML, Cancino-Diaz ME, Jimenez-Zamudio L, et al (2000) Cellular immune response to Klebsiella pneumoniae antigens in patients with HLA-B27+ ankylosing spondylitis. J Rheumatol: 1453–1460

    Google Scholar 

  • Dominguez-Lopez ML, Burgos-Vargas R, Galicia-Serrano H, et al (2002) IgG antibodies to enterobacteria 60 kDa heat shock proteins in the sera of HLA-B27 positive ankylosing spondylitis patients. Scand J Rheumatol 31: 260–265

    Article  PubMed  Google Scholar 

  • Dougados M, Boumier P, Amor B (1986) Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients. Brit J Med 293:911–914

    Google Scholar 

  • Dougados M, van der Linden S, Leirisalo-Repo M, et al (1995) Sulfasalazine in the treatment of spondylarthropathy. A randomized, multi-center, double-blind, placebo-controlled study. Arthritis Rheum 38:618–627

    PubMed  Google Scholar 

  • Dougados M, van der Linden S, Leirisalo-Repo M, et al (2000) Sulfasalazine in the treatment of spondylarthropathy. A randomized, multi-center, double-blind, placebo-controlled study. Clin Exp Pharmacol Physiol 27:295–298

    PubMed  Google Scholar 

  • Etienney I, Beaugerie L, Viboud C, Flahault A (2003) Non-steroidal-anti-inflammatory drugs as a risk factor for acute diarrhoea: a case cross over study. Gut 52:260–263

    Article  PubMed  Google Scholar 

  • Evans JM, McMahon AD, Murray FE, et al (1997) Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut 40:619–622

    PubMed  Google Scholar 

  • Faucheron JL (1999) Toxicity of non-steroidal anti-inflammatory drugs in the large bowel. Eur J Gastroenterol Hepatol 11:389–392

    PubMed  Google Scholar 

  • Feagan BG, Fedorak RN, Irvine EJ, et al (2000) A comparison of methotrexate with placebo for the maintenance of remission in Crohn’s disease. North American Crohn’s Study Group Investigators. N Engl J Med 42:1627–1632

    Google Scholar 

  • Feagan BG, Rochon J, Fedorak RN, et al (1995) Methotrexate for the treatment of Crohn’s disease. The North American Crohn’s Study Group Investigators. N Engl J Med 332:292–297

    Article  PubMed  Google Scholar 

  • Felder JB, Korelitz BI, Rajapakse R, et al (2000) Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol 95:1949–1954

    Article  PubMed  Google Scholar 

  • Fellermann K, Ludwig D, Stahl M, et al (1998) Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus. Am J Gastroenterol 93: 1860–1866

    Article  PubMed  Google Scholar 

  • Fiorucci S, Santucci L, Gresele P, et al (2003) Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study. Gastroenterology 124:600–607

    Article  PubMed  Google Scholar 

  • Fries JF (1991) NSAID-gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. J Rheumatol 18(Suppl. 28): 6–10

    Google Scholar 

  • Gibson GR, Whitacre EB, Ricotti CA (1992) Colitis induced by nonsteroidal anti-inflammatory drugs. Arch Intern Med 152:625–632

    Article  PubMed  Google Scholar 

  • Gillett HR, Arnott ID, McIntyre M, et al (2002) Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 122:800–805

    PubMed  Google Scholar 

  • Hanauer SB, Feagan BG, Lichtenstein GR, et al (2002) Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial. Lancet 359:1541–1549

    PubMed  Google Scholar 

  • Hawkey CJ, Karrasch JA, Szczepanski et al (1998a) Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 338:727–734

    Article  PubMed  Google Scholar 

  • Hawkey CJ, Langman MJ (2003) Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors. Gut 52:600–608

    Article  PubMed  Google Scholar 

  • Hawkey CJ, Tulassay Z, Szczepanski L, et al (1998b) Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention. Lancet 352:1016–1021

    Article  PubMed  Google Scholar 

  • Hench PS (1935) Acute and chronic arthritis. In: Whipple GH (ed) Nelsons Looseleaf of Ssurgery, Vol. I. Thomas Nelson Sons, New York, p 104

    Google Scholar 

  • Holden W, Orchard T, Wordsworth P (2003) Enteropathic arthritis. Rheum Dis Clin North Am 29:513–530

    Article  PubMed  Google Scholar 

  • Holtmeier W, Stein J (1999) Sprue/Zöliakie. In: Caspary WF, Stein J (Hrsg) Darmkrankheiten. Springer, Berlin, pp 283–294

    Google Scholar 

  • Huang JQ, Sridhar S, Hunt RH (2002) Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic ulcer disease. A meta-analysis. Lancet 359:14–22

    PubMed  Google Scholar 

  • Hugot JP, Chamaillard M, Zouali H, et al (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603

    PubMed  Google Scholar 

  • Hunt RH, Bazzoli F (2004) Should NSAID/low dose aspirin takers be tested routinely for H. pylori infection and treated if possible? Implications for primary risk of ulcer and ulcer relapse after initial healing. Aliment Pharmacol Ther 19:9–16

    Article  PubMed  Google Scholar 

  • Ierardi E, Principi M, Francavilla R, et al (2001) Oral tacrolimus long-term therapy in patients with Crohn’s disease and steroid resistance. Aliment Pharmacol Ther 15:371–377

    Article  PubMed  Google Scholar 

  • Jaspersen D (2000) Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management. Drug Saf 22:237–249

    PubMed  Google Scholar 

  • Kallikorm R, Uibo O, Uibo R (2000) Coeliac disease in spondyloarthropathy: usefulness of serological screening. Clin Rheumatol 19:118–122

    Article  PubMed  Google Scholar 

  • Khan MA, van der Linden SM (1990) Ankylosing spondylitis and other spondyloarthropathies. Rheum Dis Clin North Am 16:551–579

    PubMed  Google Scholar 

  • Khan MA (2002) Update on spondyloarthropathies. Ann Intern Med 136:896–907

    PubMed  Google Scholar 

  • Konstam MA, Weir MR, Reicin A, et al (2001) Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib. Circulation 104:2280–2288

    PubMed  Google Scholar 

  • Kwo PY, Tremaine WJ (1995) Nonsteroidal anti-inflammatory drug-induced enteropathy: case discussion and review of the literature. Mayo Clin Proc 70:55–61

    PubMed  Google Scholar 

  • Labenz J, Blum AL, Bolten WW, et al (2002) Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in helicobacter positive patients: a randomised, double blind, placebo controlled, clinical trial. Gut 51:329–335

    Article  PubMed  Google Scholar 

  • Laine L, Bombardier C, Hawkey Ch J, et al (2002) Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis. Gastroenterology 123: 1006–1012

    Article  PubMed  Google Scholar 

  • Laine L, Connors LG, Reicin A, et al (2003) Serious lower gastrointestinal events with non-selective NSAID or coxib use. Gastroenterology 124:288–292

    Article  PubMed  Google Scholar 

  • Lanas A, Bajador E, Serrano P, et al (2000) Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med 343:834–839

    Article  PubMed  Google Scholar 

  • Lang J, Price AB, Levi AJ, et al (1988) Diaphragm disease: pathology of disease of small intestine induced by non steroidal anti-inflammatory drugs. J Clin Pathol 41:516–526

    PubMed  Google Scholar 

  • Lemann M, Zenjari T, Bouhnik Y, et al (2000) Methotrexate in Crohn’s disease: long-term efficacy and toxicity. Am J Gastroenterol 295:1730–1734

    Google Scholar 

  • Lindgren S, Lofberg R, Bergholm L, et al (2002) Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis. Scand J Gastroenterol 37:705–710

    Article  PubMed  Google Scholar 

  • Lowry PW, Weaver AL, Tremaine WJ, Sandborn WJ (1999) Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn’s disease perianal fistulae. Inflamm Bowel Dis 5:239–245

    PubMed  Google Scholar 

  • Marshall JK, Irvine EJ (1995) Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis. Aliment Pharmacol Ther 9:293–300

    PubMed  Google Scholar 

  • Marteau P, Crand J, Foucault M, Rambaud JC (1998) Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multi-centre study. Gut 42:195–199

    PubMed  Google Scholar 

  • Mielants H, Veijs EM (1985) HLA-B27 related arthritis and bowel inflammation. Part 1, Sulfasalazine (salazopyrin) in HLA-B27 related reactive arthritis. J Rheumatol 12:287–293

    PubMed  Google Scholar 

  • Mielants H, Veys EM, Cuvelier C et al (1995) The evolution of spondylarthropathies in relation to gut histology: II. Histological aspects. J Rheumatol 22: 2273–2278

    PubMed  Google Scholar 

  • Mowat AM (2003) Coeliac disease — a meeting point for genetics, immunology, and protein chemistry. Lancet 361:1290–1292

    Article  PubMed  Google Scholar 

  • Münch H, Purrmann J, Reis HE, et al (1986) Clinical features of inflammatory joint and spine manifestations in Crohn’s disease. Hepato-Gastroenterol 33:123–127

    Google Scholar 

  • Ogura Y, Bonen DK, Inohara N et al (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411: 603–606

    PubMed  Google Scholar 

  • Orchard TR, Wordsworth BP, Jewell DP (1998) Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42:387–391

    PubMed  Google Scholar 

  • Palm O, Moum B, Ongre A, Gran JT (2002) Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). J Rheumatol 29:511–515

    PubMed  Google Scholar 

  • Papi C, Luchetti R, Gili L, et al (2000) Budesonide in the treatment of Crohn’s disease: a meta-analysis. Aliment Pharmacol Ther 14:1419–1428

    Article  PubMed  Google Scholar 

  • Pearson DC, May GR, Fick G, Sutherland LR (2000) Azathioprine for maintaining remission of Crohn’s disease. Cochrane Database Syst Rev 2:CD000067

    Google Scholar 

  • Pohle T, Brzozowski T, Becker JC, et al (2001) Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C. Aliment Pharmacol Ther 15:677–687

    Article  PubMed  Google Scholar 

  • Raskin JB, White RH, Jaszewski R (1996) Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: A prospective, double blind, multicenter sudy. Am J Gastroenterol 91:223–227

    PubMed  Google Scholar 

  • Reinisch W, Miehsler W, Dejaco C, et al (2003) An open-label trial of the selective cyclo-oxygenase-2 inhibitor rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia. Aliment Pharmacol Ther 17: 1371–1380

    Article  PubMed  Google Scholar 

  • Sandborn W, Sutherland L, Pearson D, et al (2000) Azathioprine or 6-mercaptopurine for inducing remission of Crohn’s disease. Cochrane Database Syst Rev (2):CD000545

    Google Scholar 

  • Sandborn WJ, Present DH, Isaacs KL, et al (2003) Tacrolimus for the treatment of fistulas in patients with Crohn’s disease: a randomized, placebo-controlled trial. Gastroenterology 125: 380–388

    Article  PubMed  Google Scholar 

  • Schröder O, Stein J (2003) Methotrexate in IBD. Current status and future aspects. Am J Gastroenterology 98:530–537

    Article  Google Scholar 

  • Shah AA, Thjodleifsson B, Murray FE, et al (2001) Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen. Gut 48:339–346

    Article  PubMed  Google Scholar 

  • Silverstein FE, Faich G, Goldstein JL, et al (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. JAMA 284:1247–1255

    PubMed  Google Scholar 

  • Silverstein FE, Graham DY, Senior JR, et al (1995) Misoprostol reduces serious gastrointestinal complications in patients in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: a randomized, double, placebo controlled trial. Ann Intern Med 123:241–249

    PubMed  Google Scholar 

  • Simms L, Steinhart AH (2001) Budesonide for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev (1):CD002913

    Google Scholar 

  • Smith R (1920) Treatment of rheumatoid arthritis by colectomy. Ann Surg 76:515–578

    Google Scholar 

  • Stange EF, Riemann J, von Herbay A et al (2001) Diagnosis and therapy of ulcerative colitis — results of a consensus conference of the German Society of Digestive and Metabolic Diseases. Z Gastroenterol 39:19–70

    Article  Google Scholar 

  • Stange EF, Schreiber S, Fölsch U, et al (2003) Diagnosis and therapy of Crohn diseases — results of a consensus conference of the German Society of Digestive and Metabolic Diseases. Z Gastroenterol 41:19–70

    Article  PubMed  Google Scholar 

  • Stein J, Jordan A (2003) Ernährung bei Krankheiten des Gastrointestinaltraktes. In: Stein J, Jauch KW (Hrsg) Klinische Ernährung und Infusionstherapie. Springer, Berlin, pp 582–626

    Google Scholar 

  • Stein J, Makawiec F, Starlinger RM, Caspary WF (1999) Morbus Crohn. In: Caspary W, Stein J (Hrsg) Darmkrankheiten — Klinik, Diagnostik und Therapie. Springer, Berlin, pp 439–464

    Google Scholar 

  • Stein J (1999) NSAR-Enteropathie. In: Caspary W, Stein J (Hrsg) Darmkrankheiten — Klinik, Diagnostik und Therapie. Springer, Berlin, pp 501–506

    Google Scholar 

  • Steinhart AH, Ewe K, Griffiths AM, et al (2001) Corticosteroids for maintaining remission of Crohn’s disease. Cochrane Database Syst Rev (3) CD000301

    Google Scholar 

  • Taha AS, Hudson N, Hawkey CJ, et al (1996) Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiin-flammatory drugs. New Engl J Med 334:1435–1439

    Article  PubMed  Google Scholar 

  • Tanner AR, Raghunath AS (1988) Colonic inflammation and nonsteroidal anti-inflammatory drug administration. An assessment of the frequency of the problem. Digestion 41:116–120

    PubMed  Google Scholar 

  • Targan SR, Hanauer SB, van Deventer SJ, et al (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. Crohn’s Disease cA2 Study Group. N Engl J Med 337:1029–1035

    Google Scholar 

  • Thomsen OO, Cortot A, Jewell D, et al (1998) A comparison of budesonide and mesalamine for active Crohn’s disease. International Budesonide-Mesalamine Study Group. N Engl J Med 339:370–374

    Article  PubMed  Google Scholar 

  • Tiwana H, Natt RS, Benitez-Brito R, et al (2001) Correlation between the immune responses to collagens type I, III, IV and V and Klebsiella pneumoniae in patients with Crohn’s disease, and ankylosing spondylitis. Rheumatology 40:15–23

    Article  PubMed  Google Scholar 

  • Tsujikawa T, Satoh J, Uda K, et al (2000) Clinical importance of n-3 fatty acid-rich diet and nutritional education for the maintenance of remission in Crohn’s disease. J Gastroenterol 35:99–104

    Article  PubMed  Google Scholar 

  • van den Bosch F, Kruithof E, De Vos M, et al (2000) Crohn’s disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms. Lancet 356:1821–1822

    Article  PubMed  Google Scholar 

  • Veijs EM, Mielants H (1994) Spondyloarthropathies: Enteropathic arthropathies. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, St. Louis, pp 3:35.1–88

    Google Scholar 

  • Yeomans ND, Tulassay Z, Juhász L, et al (1998) A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiin-flammatory drugs. N Engl J Med 338:719–726

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Jürgen Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Sonderkrankenanstalt — Rehabilitationszentrum Bad Ischl-Lindau Pensionsversicherungsanstalt, Bad Ischl, Österreich

    Albrecht Felkenbach

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag/Wien

About this chapter

Cite this chapter

Stein, J. (2005). Gastrointestinale Komplikationen. In: Felkenbach, A. (eds) Morbus Bechterew. Springer, Vienna. https://doi.org/10.1007/3-211-26646-1_12

Download citation

  • DOI: https://doi.org/10.1007/3-211-26646-1_12

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-00808-9

  • Online ISBN: 978-3-211-26646-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation